COM:BLACKDIAMONDTHERAPEUTICS
Black Diamond Therapeutics
- Stock
Last Close
2.43
22/11 21:00
Market Cap
288.58M
Beta: -
Volume Today
338
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | ||||||||
average payables | 284K - | 1.19M 319.01% | 2.25M 89.16% | 3.32M 47.60% | 2.99M 9.95% | 2.10M 29.80% | ||
average receivables | ||||||||
book value per share | -0.93 - | -1.11 20.10% | -1.56 40.19% | -3.59 130.04% | -6.74 87.53% | -9.22 36.88% | 0.00 100.03% | |
capex per share | -0.01 - | -0.01 49.09% | -0.00 88.19% | -0.00 570.63% | -0.07 1,635.38% | -0.01 92.94% | ||
capex to depreciation | -3.21 - | -1.73 46.16% | -0.45 74.13% | -2.73 511.17% | -13.22 384.09% | -0.38 97.14% | ||
capex to operating cash flow | 0.03 - | 0.01 72.55% | 0.00 90.53% | 0.00 219.95% | 0.03 893.71% | 0.00 91.66% | ||
capex to revenue | ||||||||
cash per share | 1.09 - | 3.70 238.23% | 4.74 27.98% | 9.57 102.03% | 5.80 39.45% | 3.38 41.68% | 0.00 99.96% | |
days of inventory on hand | ||||||||
days payables outstanding | ||||||||
days sales outstanding | ||||||||
debt to assets | 0.03 - | 0.11 333.37% | 0.18 56.73% | 0.14 22.31% | ||||
debt to equity | -0.07 - | -0.12 57.87% | -0.08 28.03% | 0.19 326.24% | ||||
dividend yield | ||||||||
earnings yield | -0.02 - | -0.02 0.10% | -0.03 96.92% | -0.06 94.43% | -0.64 928.81% | -1.29 102.38% | -0.00 99.95% | |
enterprise value | 276.21M - | 499.13M 80.70% | 1.13B 127.16% | 1.03B 9.26% | 155.55M 84.88% | 59.21M 61.93% | 123.48B 208,439.65% | |
enterprise value over ebitda | -67.35 - | -56.26 16.47% | -49.43 12.14% | -15.30 69.05% | -1.24 91.90% | -0.62 49.71% | -1.43K 229,182.67% | |
ev to operating cash flow | -117.49 - | -59.04 49.75% | -45.95 22.17% | -19.73 57.07% | -1.55 92.13% | -0.70 55.19% | -1.85K 265,843.77% | |
ev to sales | ||||||||
free cash flow per share | -0.34 - | -0.61 81.21% | -0.76 23.75% | -1.59 109.99% | -2.84 78.87% | -2.35 17.41% | -0.00 99.94% | |
free cash flow yield | -0.01 - | -0.02 81.21% | -0.02 23.75% | -0.05 158.68% | -0.53 975.60% | -1.30 144.57% | -0.00 99.96% | |
graham net net | -0.95 - | -1.13 18.83% | -1.67 48.58% | 8.91 632.51% | -7.78 187.38% | 2.26 129.09% | 0.00 99.99% | |
graham number | 3.65 - | 4.01 9.64% | 6.66 66.15% | 12.68 90.55% | 22.72 79.12% | 21.97 3.28% | 0.01 99.95% | |
income quality | 0.51 - | 0.95 85.29% | 0.70 26.07% | 0.78 10.80% | 0.80 2.84% | 0.93 17.04% | 0.81 13.28% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -63.37 - | -69.57K - | 23.75 - | |||||
interest debt per share | 0.01 - | 0.27 - | 0.79 196.03% | 0.67 15.18% | 0.00 99.92% | |||
inventory turnover | ||||||||
invested capital | -0.07 - | -0.12 57.87% | -0.08 28.03% | 0.19 326.24% | ||||
market cap | 284.09M - | 550.79M 93.88% | 1.29B 133.94% | 1.05B 18.15% | 192.89M 81.71% | 65.39M 66.10% | 123.51B 188,797.41% | |
net current asset value | -6.78M - | -15.68M 131.26% | -54.60M 248.12% | 297.64M 645.14% | -281.72M 194.65% | 87.15M 130.93% | 92.20M 5.80% | |
net debt to ebitda | 1.92 - | 5.82 203.11% | 6.74 15.79% | 0.38 94.30% | 0.30 22.70% | 0.06 78.15% | 0.39 506.02% | |
net income per share | -0.64 - | -0.64 0.10% | -1.26 96.92% | -1.99 57.84% | -3.40 71.09% | -2.33 31.66% | -0.00 99.92% | |
operating cash flow per share | -0.33 - | -0.61 85.48% | -0.76 24.76% | -1.58 109.60% | -2.77 74.64% | -2.34 15.36% | -0.00 99.94% | |
payables turnover | ||||||||
receivables turnover | ||||||||
research and ddevelopement to revenue | ||||||||
return on tangible assets | -0.57 - | -0.17 69.96% | -0.26 50.83% | -0.20 23.58% | -0.50 150.44% | -0.54 8.74% | -0.52 3.88% | |
revenue per share | ||||||||
roe | 0.69 - | 0.57 16.65% | 0.81 40.47% | 0.55 31.39% | 0.51 8.77% | 0.25 50.07% | -0.71 379.91% | |
roic | 0.62 - | 0.57 8.61% | 0.20 64.31% | 0.67 229.83% | 0.67 0.96% | 0.32 52.46% | -0.54 269.52% | |
sales general and administrative to revenue | ||||||||
shareholders equity per share | -0.93 - | -1.11 20.10% | -1.56 40.19% | -3.59 130.04% | -6.74 87.53% | -9.22 36.88% | 0.00 100.03% | |
stock based compensation to revenue | ||||||||
tangible asset value | -6.67M - | -15.54M 132.84% | -50.97M 227.95% | 307.76M 703.80% | -243.82M 179.22% | 115.69M 147.45% | 116.74M 0.90% | |
tangible book value per share | -0.93 - | -1.11 20.10% | -1.56 40.19% | 9.35 698.84% | -6.74 172.04% | 3.18 147.27% | 0.00 99.92% | |
working capital | 5.68M - | 49.11M 763.99% | 149.80M 205.04% | 305.34M 103.83% | 186.14M 39.04% | 112.44M 39.59% | 114.39M 1.73% |
All numbers in USD (except ratios and percentages)